Epi2020: Survey on health service use and quality of life in people with epilepsy

Conditions

G40

Siebenbrodt K, Willems LM, von Podewils F, Mross PM, Strüber M, Langenbruch L, Bierhansl L, Gorny I, Schulz J, Gaida B, Conradi N, Süß A, Rosenow F, Strzelczyk A.

2023-08-0345 citations

10.1186/s42466-023-00265-5

Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy

Laurent M. Willems, Milena van der Goten, Felix von Podewils, Susanne Knake, Stjepana Kovac et al. (8 authors)

CNS Drugs2023-06-0128 citations

10.1007/s40263-023-01013-8

Impact of COVID-19 pandemic on physical and mental health status and care of adults with epilepsy in Germany

Kimberly Körbel, Felix Rosenow, Margarita Maltseva, Heiko Müller, Juliane Schulz et al. (14 authors)

Neurological Research and Practice2022-09-2117 citations

10.1186/s42466-022-00209-5

Use of Health-Related Apps and Telehealth in Adults with Epilepsy in Germany: A Multicenter Cohort Study

Johann Philipp Zöllner, Anna H. Noda, Jeannie McCoy, Juliane Schulz, Panagiota‐Eleni Tsalouchidou et al. (16 authors)

Telemedicine Journal and e-Health2022-08-1920 citations

10.1089/tmj.2022.0238

Interventions

Group 1: One arm: Patients with epilepsy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: G40.x epilepsy

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
cost-of-illness as measured by questionnaire	—

Secondary

Measure	Time frame
QoL (QOLIE-31)	—

Countries

Germany

Contacts

Public ContactAdam Strzelczyk

Universitätsklinium Frankfurt

strzelczyk@med.uni-frankfurt.de06963017466

Outcome results

None listed